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Abstract
Introduction: There are four endemic serotypes of human
coronavirus (HCoV) that may cause community-acquired
pneumonia (CAP) in humans. The clinical syndrome of CAP
due to HCoVs is not well characterized. The objectives of
this study were to evaluate incidence, epidemiology, and outcomes of CAP in adults due to HCoV and to compare them
with CAP due to influenza.
Methods: The Louisville Pneumonia Study (LPS) is a
prospective observational study of hospitalized adult patients
with CAP in the city of Louisville. Patients enrolled in the LPS
in whom a respiratory viral panel polymerase chain reaction
(PCR) was obtained were evaluated. Incidence, epidemiology, and outcomes were compared for patients with a positive PCR for HCoV versus patients with a positive PCR for
influenza.

Introduction
Community-acquired pneumonia (CAP) causes significant morbidity and causes more deaths in the US
than any other infectious disease.[1] Approximately
23% percent of CAP is attributed to viruses.[2] That
figure is made up of multiple viruses including: human rhinovirus, influenza A and B viruses, respiratory syncytial virus, parainfluenza virus types 1, 2, and
3, and coronaviruses 229E, OC43, NL63, and HKU1
among others. Presently, there is an interest in CAP
due to the Coronoviridae family. Clinical aspects of
the disease are well described in children, but not
adults, especially with CAP. The Middle East Respiratory Syndrome (MERS-CoV), severe acute respiratory
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Results: From 1,974 CAP patients with a PCR performed,
HCoV was identified in 65 patients (3.3%), corresponding to
the following serotypes: HCoV-229E in 12 patients, HCoVOC43 in 38 patients, HCoV-NL63 in 6 patients and HCoVHKU1 in 9 patients. No differences were observed in clinical
presentation and early outcomes for patients with CAP due to
HCoV compared to 244 patients with CAP due to influenza.
One-year mortality after hospitalization was 32% for patients
with CAP due to HCoV versus 13% for patients with CAP due
to influenza.
Conclusions: When compared to patients with CAP due to
influenza, the clinical presentation of patients with CAP due
to HCoV is similar, but these patients have significantly worse
outcomes one year after hospitalization.

syndrome (SARS-CoV), and now the novel 2019 coronavirus (SARS-CoV-2) are well known, and fortunately
not endemic like the others.
Coronaviruses are enveloped, single-stranded RNA
viruses characterized by club-like spikes that project
from their surface. Genera that can cause human disease include alphacoronaviridae and betacoronaviridae. Endemic strains of human coronavirus (HCoV)
include -229E, -OC43, -NL63 and -HKU1. These strains
are associated mainly with illnesses of the upper respiratory and gastrointestinal tracts consistent with a common cold. Approximately 90% of epidemiological data
is from samples obtained from children; it exhibits winter seasonality, a prevalent strain that varies year to
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year, and at least one strain, HCoV-OC43, that has a
higher correlation with infections of the lower respiratory tract.[3, 4] There is minimal existing data of adults
with CAP due to HCoV. On the other hand, the clinical
course of influenza with CAP and its outcomes have
been well described, so it serves as a familiar infection
to which HCoV with CAP may be compared.
In Louisville, KY, nasopharyngeal specimens were collected as standard of care for viral testing over three
years in adult patients admitted with CAP.[5] Among
those specimens were patients with viral infections, including influenza virus and HCoV. From those data,
we sought to evaluate incidence, epidemiology, and
outcomes of hospitalized adults with CAP due to endemic HCoV and compare them to CAP due to influenza virus.

Methods
This was a secondary analysis of adult patients from
the Louisville Pneumonia Study; a large prospective
population-based cohort study of hospitalized adults
with CAP aged ≥18 years in Louisville, Kentucky. The
primary study was performed in all nine adult acutecare hospitals in Louisville over three years, from June
1, 2014 to May 31, 2016 and from October 1, 2016 to
March 31, 2017. It included 7,449 patients and defined incidence, epidemiology, and mortality of adult
patients hospitalized with CAP in an entire city.[5] The
study was exempt from informed consent. Both studies
were approved by the research offices at each participating hospital, and by the Institutional Review Board
(IRB number 11.0615).
Patients meeting screening requirements were further
screened using the following inclusion criteria: positive lung imaging for CAP by chest radiograph or
chest computed tomography plus one clinical criterion addressing cough, temperature or white blood cell
count.[5] Patients with HCoV or influenza presented
once in the study period. Multiple co-infections were
acceptable for inclusion, with the exception of HCoV
and influenza viruses together. Exclusion criteria were
as follows: non-Louisville residency, incarceration, a
diagnosis of pneumonia more than 72 hours after admission, a lack of a social security number and laboratory tests positive for both HCoV and influenza virus
in the same patient.
Variables evaluated in the medical record at the time
of enrollment are in Table 1. Pneumonia severity was
measured using the pneumonia severity index. The
four endemic strains HCoV-229E, -OC43, -NL63 and HKU1, as well as influenza A and B, were detected by
routine standard of care from a nasopharyngeal swab.
Time to clinical stability was followed up to seven days
as defined previously.[6] It required attaining four clin-
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ical criteria. Length of hospital stay was calculated by
subtracting the date of admission from the date of discharge up to 14 days; after that time-period, length of
stay was censored in an effort to capture length of stay
only related to CAP. All-cause mortality was measured
as in-hospital, 30-day, 6-month and 1-year.
Continuous variables were reported as medians and
interquartile ranges. Categorical variables were reported as frequencies and percentages. Mann-Whitney
U tests and Chi-Squared tests were used to compare
baseline characteristics between groups where appropriate. A Kaplan-Meier curve for time to mortality was
produced. Survival times were compared using logrank tests.

Results
Patients that had PCR viral tests performed in the
study totaled 1,974. Among the excluded patients, one
tested positive for both HCoV and influenza. Sixtyfive patients had HCoV, and 244 had influenza virus.
There were 23 HCoV patients with a co-infection and
45 influenza patients with a co-infection (Figure 1).
Serotypes identified in the 65 patients included: 229E
in 12 patients, OC43 in 38 patients, NL63 in 6 patients,
and HKU1 in 9 patients.
Epidemiology
The median age for patients with HCoV was 69 years,
and with influenza was 68 years (Table 1). The distribution of patients by age was highest for ages ≥65
years (Figure 2). Female patients comprised 53% of patients with HCoV, and 57% of patients with influenza.
Comorbidities were similar in both groups with four
exceptions that were small, but statistically significant:
body mass index (BMI), temperature, platelet count
and white blood cell count (Table 1). The proportion
with two or greater comorbidities was 57% in both
groups. More viral tests were performed during winter months, November to March, and the incidences
for HCoV and influenza were higher during that time
(Figure 3).
Imaging
A representative chest radiograph of a patient with
CAP due to HCoV showed a lobar infiltrate (Figure
4). Older adults with comorbidities, such as chronic obstructive pulmonary disease, and a co-infection had infiltrates concomitant with chronic lung disease (Figure
4).
Outcomes
No differences in early outcomes were found (Table 2).
For the entire population, the median time to clinical
stability was 2 days with an interquartile range (IQR)
2

ULJRI

Endemic Human Coronaviruses in Hospitalized Adults with Community-Acquired Pneumonia in the City of Louisville, Kentucky

Table 1. Characteristics of hospitalized adults admitted with community-acquired pneumonia with a positive test for either endemic human coronavirus or influenza virus. Frequency with percent or median with the interquartile range is used as marked accordingly.

Variable
Demographics
Age, median [IQR]
Sex: Male, n (%)
Race, n (%)
Black
White
Other
Current Smoker, n (%)
Nursing Home Resident, n (%)
Comorbidities
HIV
Neoplastic disease
Congestive Heart Failure
Cerebrovascular Disease
Cirrhosis
Liver Disease
Renal Disease
Diabetes
COPD
BMI, median [IQR]
Obesity (BMI > 30)

Coronavirus (n=65)

Influenza (n=244)

P

69 [52, 79]
28 (43)

68 [56, 79]
115 (47)

0.607
0.658
0.078

7 (11)
58 (89)
0 (0)
16 (25)
5 (8)

51 (21)
188 (77)
5 (2)
72 (30)
21 (9)

0.534
>0.999

Frequency (%)
0 (0)
5 (2)
11 (17)
23 (9)
12 (18)
56 (23)
10 (15)
23 (9)
1 (2)
5 (2)
4 (6)
14 (6)
14 (22)
65 (27)
19 (29)
82 (34)
25 (38)
108 (44)
25 [22, 29]
28 [23, 33]
15 (23)
89 (36)

0.542
0.135
0.543
0.248
>0.999
>0.999
0.498
0.603
0.485
0.035
0.060

Laboratory and Physical Findings
Temperature (°C)
Diastolic blood pressure (mm Hg)
Systolic Blood Pressure (mm Hg)
Respiratory Rate (breaths/minute)
Heart Rate (beats/minute)
Serum Glucose (mg/dL)
Platelets per 1000/µL
Serum creatinine (mg/dL)
Serum Potassium (mEq/L)
Serum sodium (mEq/L)
Blood Urea Nitrogen (mg/dL)
WBC per 1000/µL
Hemoglobin (g/dL)
Hematocrit (%)

Median [IQR]
37 [37, 39]
38 [37, 39]
58 [49, 69]
57 [48, 66]
115 [103, 131]
118 [100, 132]
23 [20, 28]
22 [20, 27]
108 [94, 122]
104 [91, 118]
144 [117, 197]
139 [113, 187]
231 [173, 282]
184 [152, 238]
1 [1, 1]
1 [1, 1]
4 [4, 4]
4 [4, 4]
136 [134, 140]
136 [134, 140]
17 [13, 23]
18 [13, 26]
12 [10, 17]
9 [6, 13]
12 [11, 13]
12 [11, 13]
36 [32, 39]
37 [33, 41]

0.010
0.767
0.844
0.599
0.268
0.393
0.002
0.166
0.304
0.897
0.929
<0.001
0.691
0.356

Severity of Disease (on admission)
Ventilatory Support
Vasopressors
PSI Risk Class IV/V
Altered Mental Status
Direct Admission to the ICU

Frequency (%)
4 (6)
23 (9)
2 (3)
5 (2)
40 (62)
133 (55)
11 (17)
37 (15)
12 (18)
30 (12)

0.560
0.979
0.382
0.877
0.278

Abbreviations: COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency
virus; ICU, intensive care unit; IQR, interquartile range; PSI, pneumonia severity index; WBC,
white blood cell count.
Table 2. Outcomes of hospitalized adults admitted with community-acquired pneumonia with a positive test for either endemic human coronavirus or influenza. Frequency with percent or median with the interquartile range is used as marked accordingly.

Variable
Time to clinical stability, median [IQR]
Hospitalized length of stay, median [IQR]
In-hospital mortality, n (%)
30-day mortality n (%)
6-month mortality n (%)
1-year mortality n (%)

Coronavirus (n=65)

Influenza (n=244)

P

3 [1, 5]
5 [3, 8]
1 (2)
3 (5)
14 (22)
19 (32)

2 [1, 4]
4 [3, 8]
10 (4)
21 (9)
31 (13)
39 (17)

0.152
0.621
0.540
0.418
0.134
0.041

Abbreviations: IQR, interquartile range.
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Figure 1. The proportion of each type of co-infection among hospitalized adults admitted with community-acquired pneumonia with either endemic coronavirus or influenza.

Figure 2. Characteristics of hospitalized adults admitted with community-acquired pneumonia with a positive test for either endemic human
coronavirus or influenza virus.
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Figure 3. The incidences of endemic human coronavirus and influenza during each month of the three-year study for hospitalized adults admitted with community-acquired pneumonia.

of 1-4 days, and the length of stay was 4 days with an
interquartile range of 3-7 days. Mortality was higher in
those with influenza for in-hospital and 30-day mortality (P>0.05), while it was higher in those with HCoV
for 6-month (P>0.05) and 1-year mortality (P=0.041)
(Table 2). One-year survival is shown in Figure 5, with
significant differences in survival found between the
two groups (P=0.048).

Discussion
Our data showed that outcomes, including time to clinical stability, length of stay and mortality up to six
months were similar to influenza, but the 1-year mortality was statistically different with 32% among HCoV
patients and 17% among influenza patients. The reason for this difference in mortality is unknown; however, it is clear that the Coronaviridae family, includ-
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ing MERS-CoV, SARS-CoV and SARS-CoV-2, has the
potential to cause significant morbidity and mortality.
The incidence of HCoV CAP in our study was 3.6%.
This figure is similar to what has been reported in the
literature.[2, 7]
Demographics were similar overall as well with most
cases occurring in patients >65 years and in 57% having at least two comorbidities. There were a few statistically significant differences, including temperature,
platelet count, white blood count, and body mass index, but the difference in platelet count between each
group was not clinically significant.
For patients admitted with CAP, there did not appear to
be any clinically discernable difference when considering a patient’s hospital course, but this data reveals that
a difference was found compared to influenza among
patients after a year had passed. Physicians and other
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a)

b)

Figure 4. A representative chest radiograph of (a) a 64-year-old female hospitalized with community-acquired pneumonia with a test positive for
endemic human coronavirus (no co-infection) and (b) a similar patient, but who had chronic obstructive pulmonary disease.
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Figure 5. In patients with community-acquired pneumonia, Kaplan–Meier curves for time to mortality over one year were compared between
those with endemic human coronavirus and influenza.

Table 3. Manuscripts identifying cases of adult patients hospitalized for community-acquired pneumonia with endemic human coronavirus.

a

Study

Year

Country

No. cases

HCoV strain

Deaths

Folz et al.[7]
Falsey et al.[8]
van Elden et al.[9]
van Elden et al.[10]
Woo et al.[11]
Johnstone et al.[12]
Oosterhof et al.[13]
van Gageldonk et al.[14]
Zhan et al.[15]
Das et al.[16]
Mayer et al.[17]
Galante O et al.[18]
Pianana et al.[19]
Ieven et al.[20]
Arnold et al. (Present study)

1999
2002
2002
2004
2005
2008
2010
2013
2014
2015
2016
2016
2017
2018
2020

Durham, NC
Rochester, NY
Netherlands
Netherlands
China
Canada
Denmark
Netherlands
China
France
Germany
Israel
Spain
11 European countries
Louisville, KY

1
2
1
2
9
4
1
6
2
6a
1
1
7b
6
65

HKU1
OC43
NL63
OC43
not HKU1
NL63
NL63
OC43, NL63
229E, OC43, NL63, HKU1

0
0
2
1
0
1
1
1
3c

Five definite cases, one probable and one possible.
cases due to NL63, and four possible due to OC43.

b Three confirmed
c 30-day mortality.
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primary care professionals should be aware of the longterm consequences that a seemingly innocuous HCoV
may have later for patients, especially if they are older
or have comorbidities.
Most publications regarding adults with CAP due to
HCoV are case reports or a series of ten or fewer patients. Although studies exist with larger sample sizes
tested, all reported similarly small numbers of positive patients (Table 3).[8-20] In one study of patients
with CAP, 254 viral PCR tests were performed and only
seven patients were positive for HCoV.[17] In another
study of patients with lower respiratory tract infections, 3,104 viral PCR tests were performed and only
six patients were positive for HCoV.[21] Two studies included other potentially relevant patients, but children
and adults were reported together in one study and rhinovirus and HCoV were reported together in another
study.[22, 23] Overall, 52 cases have been reported until this study; six of whom died.
Patient characteristics for adults with CAP due to viral etiologies in general have been described. In a
study of 78 patients with suspected CAP and a positive viral PCR test, the most common viruses were influenza (35%), rhinovirus (26%), RSV (9%), and coronavirus (9%).[17] The median patient age was 60 and
the predominant clinical features were cough (92%),
dyspnea (74%), sputum production (62%), and fever
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(36%). The most common underlying comorbidity was
chronic lung disease, with 27% of the patients affected.
Comparatively, in the nine adults with CAP due to
HCoV-HKU1 described by Woo et al., the mean age was
slightly older at 71 and the predominating symptoms
were again fever (80%), cough (70%), sputum production (60%), and dyspnea (60%).[12] Seven of the nine
patients had underlying comorbidities with three patients having underlying lung disease. Notably, two of
the nine patients did die, and both had severe underlying comorbidities including malignancy. Overall, the
patient characteristics were essentially clinically indistinguishable from other CAP illnesses.
One limitation of the present study was that viral PCR
panels were obtained primarily during the winter seasons as standard of practice. Another limitation of
the study was that co-infections might bias the comparisons between groups. One strength of the present
study was that it nearly doubled the number of cases
of HCoV CAP reported in the literature, providing a
significant contribution to the epidemiology of the disease.
In conclusion, HCoV is found in 3% of patients hospitalized for CAP. The clinical presentation is similar to
CAP caused by influenza. It is unclear, however, why
patients with HCoV CAP have twice the one-year mortality compared to those with influenza CAP.
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